What does this LOINC code represent?

This LOINC code identifies a lab observation, measurement, question, or clinical concept in a standardized format.

Is this enough to understand my test result?

No. The code identifies the test or observation, but the interpretation depends on the actual result, reference range, and clinical context.

LOINCActiveBoth

LOINC Code 72214-0: t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript Molgen (Bld/Tiss) [# ratio]

Name: LOINC Code 72214-0: t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript Molgen (Bld/Tiss) [# ratio]
Creator: HealthAssure Clinical Team
Published: 2026-05-21T08:59:51.524Z

72214-0 is a LOINC code used to identify t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript Molgen (Bld/Tiss) [# ratio] in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript. It is commonly used with the system or sample type Bld/Tiss.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript. It is commonly used with the system or sample type Bld/Tiss.

When is it used?

Used in lab systems, EHRs, and clinical data exchange.
May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
Status: ACTIVE
Order vs observation: Both
Method: Molgen

What it does not mean

The code identifies the observation or test, not the actual result.

Key facts

t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript

A balanced reciprocal translocation involving chromosomes 15 and 17, (15;17)(q22;q21), results in a fused transcript between PML and RARA genes. This gene fusion produces the PML-RARA fusion protein, a transcriptional repressor, which causes acute promyelocytic Leukemia (APL). Depending on the breakpoint within the PML gene, various fusion transcripts will be generatedlong (L or bcr1), variant (V or bcr2), and short (S or bcr3). Techniques like real-time PCR are used to detect the PML-RARA fused transcripts and breakpoints. An endogenous control gene transcript (e.g. ABL1, GUS or BCR) is amplified along with the fusion transcript of interest. Standard curves of known amounts of both the control and fusion transcript are used to calculate the ratio of the fusion transcript signal to the control gene signal.

ABL; ABL1; ABL1 transcript; Acute promyelocytic leukemia; APL; Blood; breakpoint cluster region 3; control gene; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Myelogenous; MYL; NR1B1; Number ratio; PCR; PML-1; PML-2; PML-3; PML-3B; PML-X; Point in time; Promyelocytic leukemia; QNT; Quan; Quant; Quantitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; RNA; T prime; t(15,17) (PML,RARA) gene translocation; t(15,17)(q22,q11.2-q12); t(15;17) BCR3; t(15;17)(PML,RARA); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript Molgen (Bld/Tiss) [# ratio]t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics methodt(15;17) BCR3/control Bld/Tt(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcriptMOLPATH.TRNLOCt(15;17)(q24.1;q21.1)(PML,RARA) Bcr3/control Transcript, Blood or tissue specimenNRto

Frequently asked questions

Code details

Code72214-0

SystemLOINC

Display namet(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript Molgen (Bld/Tiss) [# ratio]

Descriptiont(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript

Short namet(15;17) BCR3/control Bld/T

Componentt(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript

PropertyNRto

TimingPt

System (specimen)Bld/Tiss

ScaleQn

MethodMolgen

ClassMOLPATH.TRNLOC

Example units%

StatusACTIVE

Order/ObservationBoth

Flags

BillableNo

Valid clinical useNo

Source

SourceLOINC

Version2.82

Releasemain

First released2.42

Last changed2.73

Consumer names

t(15;17)(q24.1;q21.1)(PML,RARA) Bcr3/control Transcript, Blood or tissue specimen

Part names

t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcriptNRtoPtBld/TissQnMolgenNumber RatioPoint in time (spot)Blood or TissueMolecular genetics

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.